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ABSTRACT
TIA-1 (T-cell restricted intracellular antigen-1) is an
RNA-binding protein involved in splicing and trans-
lational repression. It mainly interacts with RNA via
its second and third RNA recognition motifs (RRMs),
with specificity for U-rich sequences directed by
RRM2. It has recently been shown that RRM3 also
contributes to binding, with preferential binding for
C-rich sequences. Here we designed UC-rich and CU-
rich 10-nt sequences for engagement of both RRM2
and RRM3 and demonstrated that the TIA-1 RRM23
construct preferentially binds the UC-rich RNA ligand
(5′-UUUUUACUCC-3′). Interestingly, this binding de-
pends on the presence of Lys274 that is C-terminal to
RRM3 and binding to equivalent DNA sequences oc-
curs with similar affinity. Small-angle X-ray scattering
was used to demonstrate that, upon complex forma-
tion with target RNA or DNA, TIA-1 RRM23 adopts a
compact structure, showing that both RRMs engage
with the target 10-nt sequences to form the complex.
We also report the crystal structure of TIA-1 RRM2 in
complex with DNA to 2.3 A˚ resolution providing the
first atomic resolution structure of any TIA protein
RRM in complex with oligonucleotide. Together our
data support a specific mode of TIA-1 RRM23 interac-
tion with target oligonucleotides consistent with the
role of TIA-1 in binding RNA to regulate gene expres-
sion.
INTRODUCTION
TIA-1 (T-cell restricted intracellular antigen-1) and TIAR
(TIA-1 related) are ubiquitous RNA-binding proteins that
modulate RNA metabolism at several levels effecting di-
verse functions in cell survival and inflammatory responses
(1,2). They are located in both the cytoplasm and the nu-
cleus and continuously shuttle between these two compart-
ments (3). In the nucleus, TIA-1 and TIAR are modula-
tors of alternative splicing by binding to U-rich stretches
near 5′-splice sites of target mRNAs, including those encod-
ing FGFR2, CFTR, FAS, COL2A1, human calcitonin and
TIA-1/TIAR themselves (4–8). Best characterized is the nu-
clear role of TIA-1 in promoting the inclusion of exon 6
in FAS pre-mRNA resulting in an apoptotic form of FAS
(9,10). TIA proteins also interact with DNA, potentially
providing a link between transcription and splicing (7,11).
In the cytoplasm, TIA-1 and TIAR mediate translational
repression of target mRNAs via binding to target RNAmo-
tifs present in their untranslated regions. These target se-
quences are generally A/U- or C/U-rich and through them
TIA-1/TIAR have been shown to repress the expression of
inflammatory mediators COX-2 (12), TNF- (1) as well as
HMPP-13 (13) and mRNA containing 5′-TOP (5′-terminal
oligopyrimidine) elements (14). TIA-1 and TIAR are also
key proteins in the formation of stress granules. Under con-
ditions of stress, including ER stress, heat shock, hypoxia,
exposure to arsenite or viral infection, TIA proteins, along
with their bound mRNA, are sequestered into stress gran-
ules where mRNA translation is temporarily suspended un-
til the stress is resolved and the stress granules are disassem-
bled (15–17). Most recently, TIA proteins have also been
identified as playing a role in miRNA regulation (18).
Each of these functions involves the specific recognition
of target oligonucleotide sequences by TIA-1 and TIAR.
The basis of RNA recognition by TIA proteins has hence
been a major focus of their characterization. TIA-1 and
TIAR (and their isoforms that all share ∼90% identity in
the RNA-binding regions) possess three RNA-recognition
motif (RRM) domains through which they interact with
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single-stranded oligonucleotides, followed by a C-terminal
prion-related domain (PRD) that is responsible for their
participation in stress granule formation (Figure 1) (19).
Early experiments (employing in vitro selection from an
RNA library and filter-binding assays) determined that the
preferred target of TIA-1 and TIAR proteins are U-rich se-
quences (20). Subsequently, in vivo studies identifying cellu-
lar targets of TIA proteins (using co-immunoprecipitation
and iCLIP methods) revealed that, in addition to U-rich
sequences, TIA proteins also target mRNAs containing C-
rich motifs (14,21–23). These findings were supported by
biophysical studies that showed that TIAR RRM domains
are capable of binding bothU-richRNAandUC-richRNA
sequences with nanomolar binding affinities (22).
Further insight into oligonucleotide recognition by TIA-
1 and TIAR has been provided by studies of the individual
contributions of the three RRM domains to target bind-
ing. RRM domains are the most abundant RNA binding
motif and are well known for their ability to bind most
commonly 3- to 5-nt stretches of single-stranded oligonu-
cleotide (linear stretches or loop structures) in tandem to
effect binding (24). The RRMs of a single protein can con-
tribute differentially to the overall oligonucleotide binding,
both in terms of affinity (across a nanomolar to micromo-
lar binding range) and specificity (from highly specific to
highly promiscuous). Previous work established that TIA
protein RRM2 is predominantly responsible for the ob-
served U-rich RNA binding, with negligible contributions
from RRM1 or RRM3, although RRM3 was shown to
have some RNA-binding capacity (20). It was subsequently
found that RRM1 of TIAR preferentially binds to DNA
and likely plays a role in the process of transcriptional ac-
tivation (11). The contribution of RRM3 to RNA binding
remainedmysterious with studies using isothermal titration
calorimetry (ITC) and surface plasmon resonance (SPR)
showing only very small contributions to binding to U-
rich sequences (22,25). In order to determine whether the
contributions to TIA protein binding by RRM3 might de-
pend upon recognition of a specific sequence (other thanU-
rich RNA) a nuclear magnetic resonance (NMR) approach
based on a scaffold-independent analysis was used (26). In-
terestingly a C-rich RNA motif (5′-ACUCC-3′) was iden-
tified and confirmed to be bound by TIA-1 RRM3 using
SPR. Thus it was recognized that, while RRM3 was able
to contribute to binding of U-rich sequences, its physiolog-
ical role was likely to elicit TIA protein binding specificity
towardUC-rich sequences observed to be physiological tar-
gets such as FAS pre-mRNA and TOP elements (9,14).
The current study thus investigates the binding of TIA-
1 RRM23 (the tandem RRM2 and RRM3 domains of
TIA-1) to designed oligonucleotide sequences that com-
bine the U-rich target of RRM2 and the C-rich target of
RRM3. We discovered the importance of the RRM23 con-
struct design, with amino acids outside the strictly defined
RRM domains making important contributions to bind-
ing affinity. We confirmed that binding to target RNA se-
quences involves both RRM2 and RRM3 and that bind-
ing to equivalent DNA sequences occurs with similar affini-
ties. Importantly we demonstrated that binding of TIA-
1 RRM23 to a ‘UC-rich’ RNA sequence (in which the
U-rich sequence is 5′ to the C-rich sequence) occurs with
significantly higher affinity than to a ‘CU-rich’ RNA se-
quence (in which the U-rich sequence is 3′ to the C-rich
sequence). This indicates that the TIA-1 RRM23 preferen-
tially binds to target oligonucleotides with tandem RRMs
arranged in a 5′ to 3′ direction. We also present small-
angle X-ray scattering (SAXS) data that provide structural
information for the TIA-1 RRM23 construct in complex
with target oligonucleotides. Lastly, we present the X-ray
crystallography structure of TIA-1 RRM2 in complex with
oligonucleotide that provides, for the first time, atomic res-
olution structural information for the recognition of U-rich
sequences by RRM2. Together these findings further our
understanding of TIA-1 RNA binding and recognition of
target UC-rich sequences.
MATERIALS AND METHODS
Expression and purification of the TIA-1 RRM23 domains
DNA segments containing the TIA-1 central domains,
TIA-1 RRM23L (residues 80–292) and TIA-1 RRM23S
(residues 94–272), were cloned into pETM-11 vector; TIA-1
RRM23K (residues 93–274) was cloned into pETtrx 1a vec-
tor (European Molecular Biology Laboratory, Heidelberg,
Germany). TIA-1 RRM2L (residues 80–188) was prepared
as previously reported (27). The proteins were expressed in
the Escherichia coli strain Rosetta 2 (DE3). The culture was
grown until an OD600 of 0.6–0.8 was reached, and induced
with 0.5 mM IPTG and grown at 18◦C overnight. The cells
were harvested by centrifugation and resuspended in ice-
cold lysis buffer (50 mM HEPES pH 7.4, 300 mM NaCl,
5% glycerol). The cells were disrupted using an Avestin cell
homogenizer. The N-terminal poly-histidine (His-tag) pro-
tein constructs were purified using Ni-NTA agarose (QIA-
GEN). The His tag was removed by incubating protein with
TEVprotease (Promega) overnight at 4◦C followed by a sec-
ond round of Ni-NTA affinity chromatography to separate
the solubility tags from the cleaved protein. The final purifi-
cation step was achieved by size-exclusion chromatography
using a Superdex 75 16/60 column (GE healthcare) in stor-
age buffer (20 mMHEPES pH 7.0, 100 mMNaCl, 3% glyc-
erol). All purified constructs were concentrated and kept at
−80◦C. The purity of protein obtained was >95% as de-
termined from Coomassie Blue staining following sodium
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE).
Preparation of 15N-labeled TIA-1 RRM2
15N labeled TIA-1 RRM2S (residues 95–184) was prepared
for NMR studies as previously described (28). 15N labeled
RRM2S was expressed in E. coli BL21(DE3) cells as a His-
tagged protein and was purified by nickel affinity chro-
matography (Ni Sepharose 6 Fast Flow, GEHealthcare) ac-
cording to earlier protocols (26,29). TheHis-tagwas cleaved
using TEV protease (AcTEV Protease, Life Technologies)
and removed by a second nickel affinity chromatography
purification. The protein was dialyzed into 20 mM potas-
sium phosphate buffer containing 50 mM KCl (pH 5) and
concentrated to 70 M. 5′TTTTT3′ DNA oligonucleotide
was chemically synthesized (IDT, Integrated DNA Tech-
nologies; 1 mmol synthesis) and solubilized in 20 mM
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Figure 1. TIA-1b protein constructs and alignment with other TIA protein isoforms (A) TIA-1 protein domain structure schematic showing the constructs
used in this study. (B) Sequence alignment of TIA isoforms indicating the secondary structural elements in white font, and the position of conserved RNP
motifs in red boxes.
potassium phosphate buffer containing 50 mM KCl (pH
5.0) to a final concentration of 2 mM.
Fluorescence anisotropy experiments
The oligonucleotides used for fluorescence anisotropy
experiments were 5′-ACUCCUUUUU-3′ (CU-
rich RNA); 5′-ACTCCTTTTT-3′ (CT-rich DNA);
5′-AUUCUCCUUU-3′ (FAS RNA sequence);
5′-ATTCTCCTTT-3′ (FAS DNA sequence); 5′-
UUUUUACUCC-3′ (UC-rich RNA); 5′-TTTTTACTCC-
3′ (TC-rich DNA). The oligonucleotides were chemically
synthesized carrying a 5′ fluorescein label and supplied as
HPLC purified oligonucleotides (RNA from Dharmacon
research and DNA from Invitrogen). The RNA was depro-
tected according to the manufacturer’s instructions. Both
RNA and DNA were diluted to a final concentration of 1
M in 10mMHEPES pH 7, 100mMNaCl. Purified TIA-1
RRM23 protein (10 mM HEPES pH 7, 100 mM NaCl,
3% glycerol) was added at increasing concentrations to a
constant concentration of fluorescein-labeled RNA/DNA
(1 nM). Experiments were performed in triplicate using a
PHERAstar plate reader (BMG LabTech). Data were an-
alyzed using 1:1 Langmuir interaction model to determine
the affinities (KD) of protein–RNA/DNA interactions.
SAXS analysis
TIA-1 RRM23K protein both in apo-form and in a
1:1.2 molar ratio with 10-mer 5′-UUUUUACUCC-
3′ (UC-rich RNA), 5′-TTTTTACTCC-3′ (TC-rich
DNA), 5′-ACUCCUUUUU-3′ (CU-rich RNA) and
5′-ACTCCTTTTT-3′ (CT-rich DNA) were centrifuged
at 13 200 × g for 15 min before data collection. SAXS
data were collected at the SAXS-WAXS beamline at the
Australian Synchrotron. Samples at various concentrations
(0.625, 1.25, 2.5, 5.0 mg/ml protein) were loaded as vol-
umes of 60 l into a 96-well plate (Axygen) and sealed with
silicone sealing mat. The samples were run as sequentially
using an autoloader system with each sample taken up into
the quartz capillary using an autoloader. After analysis the
sample was returned back into the 96-well plate. The SAXS
data reduction was performed using software ‘scatterBrain’
developed at the Australian Synchrotron. The SAXS data
averaging, buffer blank subtraction, and further processing
were performed using the program PRIMUS and ATSAS
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software (30). DAMMIF (31) was used to calculate 15
ab intio dummy atom models from scattering curve. The
models were superposed, merged and filtered using the
program DAMAVER (32).
Crystallization and data collection
The purified proteins (TIA-1 RRM23L and TIA-1
RRM23K) were concentrated to 630 M using an Eppen-
dorf concentrator with a molecular weight cutoff limit of
10 K at 4◦C. TIA-1 RRM23 complexes were formed with
5′-ACTCCTTTTT-3′ and 5′-ATTCTCCTTT-3′ oligonu-
cleotides (Dharmacon research) to a final protein:RNA
ratio of 1:1.2. The sitting drop method was employed for
crystallization trials by mixing a 1:1 ratio of sample and
reservoir solution using screens including MIDAS, PGA
(Molecular Dimension), PACT (QIAGEN), Natrix (Sigma)
and PEG/Ion (Hampton Research). Crystallization ex-
periments were set up at the Monash Macromolecular
Crystallization Facility (Monash University). TIA-1
RRM23/DNA complex crystals were obtained for TIA-1
RRM23L combined with 5′-ACTCCTTTTT-3′ in 25%
(W/V) polyethylene glycol 1500, 10% (V/V) malonate-
imidazole-borate, pH 8 (from the PACT screen). TIA-1
RRM23K complexes were formed with 5′-ACTCCTTTTT-
3′ and 5′-ATTCTCCTTT-3′ oligonucleotides (Dharmacon
Research) at the final protein:oligonucleotide ratio of 1:1.2.
Both crystallized in 0.1 M Potassium Chloride, 25 w/v
Sokalan CP-7, 0.1 M HEPES pH 7. The crystals were
flash-cooled in liquid nitrogen prior to data collection.
X-ray data were collected at the high-throughput micro-
focus MX2 beamline at the Australian Synchrotron at a
wavelength of 0.954 A˚ using an ADSC quantum 315r de-
tector and BLU-ICE software for data acquisition (33).
The diffraction data were integrated and scaled using
XDSME (34). The reported crystal structure of the apo-
TIA-1 RRM2 (PDB ID: 3BS9) was used as a search model
for molecular replacement using the program PHASER
(35). Several rounds of structure refinement were completed
using PHENIX (36) and COOT (37). The data collection
and refinement statistics are summarized in Table 1. Figures
were produced using PYMOL (38).
NMR spectroscopy
Two-dimensional (2D) 1H-15NHSQC experiments were ac-
quired for the free andDNA-bound TIA-1RRM2S domain
(1:1.2 ratio) at 283 K on a 500 MHz Bruker AVANCE III
spectrometer provided with a cryoprobe (CITIUS NMR
services, University of Sevilla). A 30 M sample of 15N-
labeled RRM2 was prepared in 20 mM potassium phos-
phate buffer and 50 mM KCl containing 90% H2O and
10% D2O at pH 5. For the DNA-bound complex, also per-
formed at pH 5.0, a 5′-TTTTT-3′ oligonucleotide was added
to the previous sample at a final concentration of 36 M.
The spectral windows of 2D 1H-15N HSQC were fitted to
15 ppm (1H) and 145 ppm (15N), centered at 4.7 and 152.5
ppm, respectively. An additional NMR spectrum using a
15N spectral window with the same width (145 ppm) but
centered at 162.5 ppmwas recorded in order to demonstrate
that the 1J (N-H) couplings of His96 imidazole group were
not aliased.
Table 1. Data collection and refinement statistics
TIA-1 RRM2 TTT
Data collection
Space group P 65
Cell dimensions
a, b, c (A˚) 45.43 45.43 84.90
α, β, γ (◦) 90 90 120
Resolution (A˚) 22.97-2.31 (2.44-2.31)
Rsym 4.5 (62.1)
I/I 35.07 (5.17)
Completeness (%) 99.9%
Mutiplicity 12.6
CC1/2 100 (97.1)
Refinement
Resolution (A˚) 2.31
No. reflections 4381 (441)
Rwork 0.2277 (0.3179)
Rfree 0.2605 (0.3509)
No. atoms 681
Protein residues 80
DNA residues 3
Water 5
Ramachandran favored (%) 96
Ramachandran outliers (%) 0
RMS bond lengths (A˚) 0.005
RMS bond angles (◦) 0.91
RESULTS
Binding of TIA-1 RRM23 to RNA and DNA
Although early work suggested that TIA-1 binding to tar-
getRNAoccurs primarily throughRRM2 interactionswith
U-rich sequences, more recent work has established a role
for RRM3. In particular, a pentameric C-rich consensus
motif was established for TIA-1 RRM3 binding (26). We
therefore set out to characterize the way in which these two
adjacent RRMs interact with target RNAs comprised of
both U-rich and C-rich regions. The ‘CU-rich’ sequence 5′-
ACUCCUUUUU-3′ consists of a pentamer of the RRM3
consensus sequence (ACUCC) followed by a poly-U pen-
tamer consistent with established RRM2 RNA-binding
data. These are arranged such that RRM23 binding can
occur in the 3′ to 5′ direction from RRM2 to RRM3 (i.e.
3′-5′ / N-C) as seen for many tandem RRM interactions
with RNA that have been structurally characterized (e.g.
PDB IDs: 1CVJ, 4ED5, 1FJE). The ‘UC-rich’ sequence 5′-
UUUUUACUCC-3′, in contrast, positions the pentamer
consensus sequences in the reverse order.
TIA-1 RRM23 constructs were initially cloned, includ-
ing a ‘long’ sequence (TIA-1 RRM23L; residues 80–292),
and a ‘short’ sequence (TIA-1 RRM23S; residues 94–272)
(Figure 1A). Note that we selected TIA-1 isoform b, which
lacks an insertion between RRM 1 and 2 compared to iso-
form a; (Figure 1B). The latter ‘short’ sequence was de-
signed to span only the well-defined secondary structural el-
ements of RRM2 and RRM3, as well as the linker between
them, according to their determined three-dimensional
apo-structures (PDB IDs: 2MJN, 2DGO, 2RNE, 3BS9). It
was anticipated that this construct would bemore amenable
to crystallization. These constructs were readily overex-
pressed and purified for biophysical study.
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Fluorescence anisotropy was used to determine the
binding affinity of TIA-1 RRM23L and RRM23S
to the 5′-FITC-labeled CU-rich RNA sequence: 5′-
ACUCCUUUUU-3′ as well as the equivalent CT-rich
DNA sequence: 5′-ACTCCTTTTT-3′ for comparison.
Figure 2A shows the binding curves obtained for the
interactions as well as the determined binding affinities.
Interestingly, while the TIA-1 RRM23L construct bound
to the RNA with an equilibrium dissociation constant of
KD = 0.13 ± 0.007 M, the TIA-1 RRM23S construct
bound with a lower affinity KD = 6.6 ± 0.7 M. Binding
to DNA was of slightly higher affinity, but also showed this
trend of loss of affinity by the shorter construct. Together
this demonstrated that TIA-1 RRM23 binds to both RNA
and DNA target sequences with micromolar affinity and
that residues N- or C-terminal to the well-defined RRM
regions are important in contributing to oligonucleotide
binding.
Previous studies of TIAR RRM2 demonstrated the im-
portance of a lysine residue immediately C-terminal to the
well-defined secondary structure of RRM2 (39) leading us
to consider whether Lys274, that is located 2 amino acid
residues C-terminal to the TIA-1 RRM3 domain might
similarly be important to binding by RRM3. We therefore
prepared a third construct, TIA-1 RRM23K (residues 93–
274), that includes Lys274 and repeated the binding exper-
iments as shown in Figure 2A. The inclusion of the extra
residues completely restored the RNA andDNAbinding of
the TIA-1 RRM23K construct toKD = 0.13M± 0.01 and
KD = 0.03 M± 0.003 respectively, demonstrating that the
higher binding affinity observed for TIA-1 RRM23L was
due to these extra N- and C-terminal residues––most likely
due to the contribution of Lys274 to oligonucleotide inter-
actions.
It was also of interest to measure the binding affinity of
the TIA-1 RRM23K construct for a physiological sequence
for comparison with the consensus motif derived sequence.
We thereforemeasured the binding of TIA-1RRM23K con-
struct to a sequence (5′-AUUCUCUUU-3′) derived from a
region ofFAS pre-mRNA that has previously been reported
to be bound by TIA-1 (40) as well as its DNA equivalent.
Figure 2B shows the fluorescence anisotropy-derived bind-
ing curves to 5′-FITC labeled RNA and DNA sequences.
The binding affinities to these sequences were almost iden-
tical to those determined for the consensusmotif-derived se-
quences, withKD = 0.14 M± 0.03 for RNA and a slightly
higher affinity of KD = 0.05 M ± 0.05 for DNA.
In order to determine the contribution of TIA-1 RRM3
toward binding to the CU-rich RNA sequence, the bind-
ing of TIA-1 RRM2 (residues 80–188) was tested with 5′-
ACUCCUUUUU-3′ RNA. The KD calculated for the iso-
lated RRM2 with CU-rich RNA was 9.1 ± 2 M, as com-
pared toTIA-1RRM23L with aKD = 0.13M(Figure 2C),
confirming that RRM3 makes a significant contribution in
increasing the affinity toward binding to RNA.
Oligonucleotide binding by TIA-1 RRM23 occurs in a 5′ to
3′ orientation
Finally we examined whether oligonucleotide sequences
in which the two pentamer target sequences were re-
versed in order showed any difference in their affinity of
binding by TIA-1 RRM23K. Thus we performed fluo-
rescence anisotropy experiments with the 5′-FITC-labeled
UC-rich RNA sequence: 5′-UUUUUACUCC-3′ as well as
the equivalent DNA TC-rich sequence: 5′-TTTTTACTCC-
3′ for comparison (Figure 2D). To our surprise, binding by
TIA-1 RRM23K was enhanced to KD = 0.005 ± 0.0003
M and KD = 0.008 ± 0.001 M respectively––both with
higher affinity compared to the RNA and DNA sequences
in which theRRM3 target motif was placed 5′ to theRRM2
target motif. In order to confirm this unexpected result, we
also used ITC to measure the affinity of TIA-1 RRM23K
for non-FITC labeled UC-rich RNA sequence (UUUU-
UACUCC) compared to the CU-rich sequence (ACUCCU-
UUUU). Consistent with the fluorescence anisotropy bind-
ing experiments, we found that TIA-1 RRM23K binding
to the UC-rich RNA was significantly higher (KD = 0.012
± 0.002 M) than binding to the CU-rich sequence (KD
= 0.07 ± 0.003 M) (Supplementary Figure S1 and Ta-
ble S1). This finding suggests that TIA-1 RRM23 adopts a
more favorable interaction with oligonucleotides when tan-
dem binding is in the parallel 5′ to 3′ orientation (i.e. 5′-3′/
N-C).
To further verify the 5′-3′ orientation of the binding of
TIA-1 RRM23 to DNA, paramagnetic NMR spectroscopy
was performed by labeling the thiol group at 5′ of a TC-
rich DNA (5′thiolTC-rich DNA) with the paramagnetic
tag 3-(2-Iodoacetamido)-proxyl (PROXYL) (Supplemen-
tary Figure S2A). If TIA-1 RRM23 binds to the TC-
rich DNA in a parallel orientation (5′-3′ / N-C), the dis-
tance of the paramagnetic spin label to RRM2 should be
shorter than that to RRM3. This fact would lead to a
higher paramagnetic effect in resonances from RRM2 than
those from RRM3. In order to test this, 15N HSQC spectra
were recorded upon binding TIA-1 RRM23 to the diamag-
netic (5′thiolTC-rich DNA) and paramagnetic (PROXYL-
modified) DNA. Although a general paramagnetic effect
was observed for all TIA-1 RRM23 resonances involved in
DNAbinding due to the short length of the DNAmolecule,
the effect was substantially more pronounced in TIA-1
RRM2 (Supplementary Figure S2B). We therefore quan-
tified intensity changes of the NMR signals in the DNA
binding regions (RNP1 and RNP2 in the RRMs (Supple-
mentary Figure S2C)) upon spin labeling. Consistent with
a 5′-3′/N-C orientation, the resonances with a higher drop
in their intensity under paramagnetic conditions were in-
cluded in the RNP2 and RNP1 of RRM2 (stretches Val97-
Leu102 and Lys136-Ser142) and the surroundings RNP2
residues Ser103 and Glu105 (Supplementary Figure S2D).
TIA-1 RRM23 engages with target RNA and DNA to form
a compact structure
In order to obtain structural information, SAXS was
used to characterize the solution structure of TIA-
1 RRM23K, in apo-form and in complex with each
of the consensus sequence derived oligonucleotides: 5′-
ACUCCUUUUU-3′ (CU-rich RNA), 5′-ACTCCTTTTT-
3′ (CT-rich DNA), 5′-UUUUUACUCC-3′ (UC-rich RNA)
and 5′-TTTTTACTCC-3′ (TC-richDNA). SAXS data were
collected at the SAXS/WAXS beamline of the Australian
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Figure 2. Fluorescence anisotropy binding curves for TIA-1 RRM23 interactions with RNA and DNA sequences. (A) The binding of TIA-1 RRM23L,
TIA-1 RRM23S and TIA-1 RRM23K to CU-rich RNA (top) and CT-rich DNA (bottom), (B) TIA-1 RRM23K binding to a FAS-derived RNA sequence
(top) and the corresponding DNA sequence (bottom), (C) TIA-1 RRM2 L binding to UC-rich RNA and (D) TIA-1 RRM23K binding to UC-rich RNA
and TC-rich DNA. Increasing concentrations of protein were added to a constant amount of the fluorescent RNA and DNA. Data points represent
triplicate samples and the errors shown are standard errors of the mean (SEM). The binding data were fit by the 1:1 Langmuir binding model to derive the
KD.
Synchrotron for both the apo-TIA-1 RRM23K and the pro-
tein in complexwith oligonucleotide over a range of concen-
trations (0.6, 1.25, 2.5 and 5.0 mg/ml). The radius of gyra-
tion (Rg) estimated from the Guinier region of the scatter-
ing data showed fairly consistent values at the three lower
concentrations, but increased above 2.5 mg/ml suggesting
that aggregation was taking place above this concentration
(Supplementary Figure S3). The scattering curves obtained
at 2.5 mg/ml protein are shown in Figure 3A and were used
for further analysis.
In the case of the apo-TIA-1 RRM23K protein, the pair-
wise density distribution function (P(r)) plot showed multi-
modal features tailing toward amaximumdimension (Rmax)
of 84 A˚ (Figure 3B and Table 2). The normalized Kratky
plot showed a non-parabolic curve that did not completely
return to zero and had a maxima not placed at 1.1 for a
value of sRg = √3 (Figure 3C). This pattern is indicative
of the presence of both globular and partially disordered
regions in the protein (41). These data are thus consistent
with apo-TIA-1 RRM23K behaving in solution as a pair of
RRM domains connected by a flexible linker, as would be
expected.
Scattering curves obtained for TIA-1 RRM23K in com-
plex with the UC-rich RNA showed a distinct change of
shape indicative of the formation of a more compact and
less flexible structure upon binding to the oligonucleotide.
The P(r) plot is unimodal with some tailing toward an Rmax
value of 65 A˚ (Figure 3B and Table 2). The shape of the nor-
malized Kratky plot is parabolic with maxima close to 1.1
for a value of sRg = √3 and returns to low values, consistent
with the formation of a well-defined complex (Figure 3C).
In order to visualize the shape of TIA-1 RRM23K in com-
plex with oligonucleotide, DAMMIF (31) was used to cal-
culate the three-dimensional, ab initio shape reconstruction
of TIA-1RRM23K in complexwith theUC-richRNA (Fig-
ure 3D). It reveals a slightly elongated oblate shape consis-
tent with two RRMs positioned adjacent to one another. In
the case of TIA-1 RRM23K in complex with TC-richDNA,
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Figure 3. SAXS analysis of apo-TIA-1 RRM23K, TIA-1 RRM23K/RNA and TIA-1 RRM23K/DNA complexes. (A) The scattering intensity (I) is plotted
in arbitrary units (au) versus the forward scattering vector (s) in the units of inverse A˚ for TIA-1 RRM23K (abbreviated TIA23K) before and after being
combined with RNA and DNA sequences (sequences as indicated). The error bars in gray indicate the mean ± SD. (B) P(r) profiles calculated from the
scattering data are plotted against r in the units of A˚. (C) Normalized Kratky Plots for TIA-1 RRM23K calculated from the scattering data are shown
across units of sRg. (D) Ab initio shape reconstruction determined for the TIA-1RRM23K /UUUUUACUCC complex using DAMMIF (NSD = 0.66 ±
0.04) (31). Superposed are ribbon representations of TIA-1 RRM2 and RRM3 derived from the NMR structure PDB ID: 2MJN to show the relative scale
of the ab initio shape.
Table 2. SAXS data collection and scattering parameters
TIA-1 RRM23K
TIA-1 RRM23K
+UC-rich RNA
TIA-1RRM23K
+TC-rich DNA
TIA-1 RRM23K
+CU-rich RNA
TIA-1RRM23K
+CT-rich DNA
Data collection scatterBrain scatterBrain scatterBrain scatterBrain scatterBrain
Wavelength (A˚) 1.03320 1.03320 1.03320 1.03320 1.03320
q range (A˚−1) 0.006–0.35 0.006–0.35 0.006–0.35 0.006–0.35 0.006–0.35
Exposure time (s)a 2 2 2 2 2
Concentration (mg ml−1) 2.5 2.5 2.5 2.5 2.5
Temperature (K) 288 288 288 288 288
Structural parametersb
I(0) (cm−1) [from P(r)] 0.04 0.06 0.04 0.06 0.06
Rg (A˚) [from P(r)] 24.6 20.9 21.4 21.5 21.8
Rg (A˚) [from Guinier] 23.1 20.8 21.1 21.7 21.8
I(0) (cm−1) [from Guinier] 0.04 0.06 0.04 0.06 0.06
Rmax (A˚) 84 65 71 66 67
Porod volume estimate (A˚3) 25 332 26 481 32 006 29 869 30 591
Molecular mass determinationb
Mr [Porod volume] 18.8 kDa 17.6 kDa 21.3 kDa 18.5 kDa 21.8 kDa
CalculatedMr from sequence 20.2 kDa 23.7 kDa 23.1 kDa 23.7 kDa 23.1 kDa
Data processing PRIMUS PRIMUS PRIMUS PRIMUS PRIMUS
aFifteen frames of 2 s exposure were recorded for each sample, and averaged.
bReported for a 2.5 mg/ml measurement.
the scattering and P(r) plot look very similar, indicative of
a compact complex also formed with the DNA (Figure 3A
and B). The normalizedKratky plot, however, shows higher
values across sRg, indicative of a slightly increased flexibil-
ity of this complex with DNA (Figure 3C).
Scattering curves and P(r) plots obtained for TIA-1
RRM23K in complex with the CU-rich RNA and CT-rich
DNA also showed similar profiles (Figure 3A and B), indi-
cating that whenTIA-1RRM23K binds to these lower affin-
ity oligonucleotides, it still adopts a more compact and less
flexible structure in solution. Interestingly, the normalized
Kratky plots reveal subtle differences for these complexes
compared to the complexes formed with the UC-rich RNA
and TC-rich DNA counterparts. In both cases the curves
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are slightly higher beyond sRg = √3 values, indicative of a
subtle increase in flexibility or difference in shape of these
complexes (Figure 3C). Together this indicates that binding
by both RRMs still takes place to these oligonucleotides
in which the target consensus sequences for RRM2 and
RRM3 are arranged in a 3′ to 5′ direction; however the com-
plexes formed do have a slight difference in their shape or
flexibility.
The differences between the scattering data can be further
evaluated using the ensemble optimization method (42).
This method involves the in silico generation of a large
pool of molecular models of the system from which a min-
imal subset are selected that together predict the scattering
curve. For this theNMRmodel of TIA-1RRM23 (PDB ID:
2MJN) was used as a starting point with or without RNA
modeled across the face of RRM2. A total of 10 000 mod-
els were generated in which each of the RRMs was held as a
rigid body and the linker allowed to randomly explore con-
formational space using a Monte Carlo algorithm. Figure
4A shows the frequency distribution of molecular models
of apo-TIA-1 RRM23K in the pool plotted against Rmax
and Rg. Superposed is a frequency distribution indicating
the distribution of selected models that together best pre-
dicted the apo-TIA-1 RRM23K scattering data ( 2 = 0.34).
In this case, two populations of models are apparent––one
with a small average Rmax and Rg, and the other with an av-
erageRmax andRg at the longest and largest end of the pool.
This is a reflection of the dynamics of the system with TIA-
1 RRM23K existing in equilibrium between more compact
and more extended forms.
Figure 4B shows the frequency distributions of selected
molecular models of TIA-1 RRM23K bound to oligonu-
cleotide that predict the scattering curves derived for TIA-
1 RRM23K bound to the four different oligonucleotides
( 2 ≤ 0.44 in all cases; fits shown in Supplementary Fig-
ure S4). In all cases there were two populations selected––a
main population at the low end of Rmax and Rg indicative
of a compact structure, and a much smaller population at
the longer and larger end of these parameters indicative of
the presence of some elongated molecules. This again likely
reflects an equilibrium between compact TIA-1 RRM23K
bound to oligonucleotide and partially unbound species
but, in contrast to the apo-TIA-1 RRM23K structure, with
the equilibrium lying well toward the compact, fully bound
structure. Interestingly, upon close examination of the sub-
set of elongated structures it can be seen that, in the case
of TIA-1 RRM23K in complex with the CU-rich RNA and
CT-richDNA, the selected ensemble is shifted further to the
right than in the cases of TIA-1 RRM23K in complex with
UC-rich RNA and TC-rich DNA. In other words, the data
suggest that the complexes formed with the higher affin-
ity UC-rich RNA and TC-rich DNA have slightly differ-
ent structures compared to the complexes formed with the
lower affinity CU-rich RNA and CT-rich DNA.
SAXS experiments were also conducted with TIA-1
RRM23L and the CU-rich and CT-rich oligonucleotides
in order to see whether TIA-1 RRM23L construct by it-
self and in complex with oligonucleotide behaves similarly
to TIA-1 RRM23K. SAXS analysis showed that apo-TIA-
1 RRM23L behaves as an extended molecule in solution.
Upon complex formation with CU-rich oligonucleotide a
more compact arrangement of two RRM domains was ob-
served (Supplementary Figure S5 and Table S2). These data
are consistent with the TIA-1RRM23L construct also bind-
ing the target oligonucleotides with both RRMs engaged to
form a stable complex.
Crystal structure of TIA-1 RRM2 in complex with T-rich
DNA
Having established that TIA-1 RRM23 forms a complex
with the 10-mer RNA and DNA, with both RRMs en-
gaged, we were interested to examine the structural basis
for TIA-1 recognition of the target nucleotide sequence.
TIA-1 RRM23L and TIA-1 RRM23K were combined with
CU-rich andUC-richRNAand equivalentDNA sequences
and subjected to crystallization trials. TIA-1 RRM23L co-
crystallized with 5′-ACTCCTTTTT-3′ DNA, forming crys-
tals that diffracted to 2.3 A˚ resolution. These crystals were
determined to belong to space group P 65, with unit cell
dimensions a = b = 45.43 A˚ and c = 84.9 A˚. The structure
was solved bymolecular replacement, using the structure of
the RRM2 domain of TIA-1 (PDB ID: 3BS9) as a search
model.
Unexpectedly, only a single RRM domain with bound
nucleotide was visible in the electron density. The density
was consistent with the presence of the RRM2 sequence
and not RRM3 suggesting that protein cleavage had oc-
curred resulting in an RRM2 product that had crystallized
with the bound oligonucleotide. To investigate this possi-
bility, a crystal was picked from the well, washed in fresh
buffer and examined using SDS-PAGE. Indeed, a smaller
band corresponding to the molecular weight of a single
RRMpredominated, suggesting that proteolytic cleavage of
RRM23 had occurred, and that the single RRM2, in com-
plex with the oligonucleotide, had preferentially crystallized
(Supplementary Figure S6). Repeated efforts to form crys-
tals using the TIA-1 RRM23K construct in the presence
of protease inhibitors resulted in two further crystals being
formed with 5′-ACTCCTTTTT-3′ and 5′-ATTCTCCTTT-
3′ DNA (that diffracted to 2.9 and 2.8 A˚ resolution respec-
tively and the same space group and unit cell dimensions
as above). Upon solving their structures, the electron den-
sity was found, once more, to contain only RRM2 bound
to oligonucleotide, with no sign of RRM3. The structures
obtained, nevertheless, represent the first example of a TIA
protein RRM structure solved in the presence of oligonu-
cleotide. They therefore present a unique opportunity to
observe the detailed interactions via which TIA-1 RRM2
recognizes target oligonucleotide.
The refinement of the 2.3 A˚ resolution TIA-1
RRM2/DNA structure was completed using PHENIX
(36). The refined model consists of 80 amino acids
(Residues 92–171 could be seen in the electron density),
three nucleotides and four ordered water molecules. The
nucleotide density in the model was consistent with three
thymine residues out of ten DNA nucleotides. No density
was observed on either side, likely due to flexibility of the
DNA outside the bound region. The refined model has
good statistics with an R-factor of 0.2277 (free R-factor
0.2605). The Ramachandran plot showed all backbone
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Figure 4. Ensemble optimization analysis of apo-TIA-1 RRM23K, TIA-1 RRM23K/RNA and TIA-1 RRM23K/DNA complexes. Rmax and Rg distribu-
tions from the best fitting ensembles were calculated using ensemble optimization method (42). (A) The distribution of the pool of 10 000 models (dotted
line) and the selected best fitting ensemble (solid line) are shown for apo-TIA-1 RRM23K (abbreviated TIA23K APO). (B) The distribution of the pool of
10 000 models (dotted line) and the selected best fitting ensemble are shown for TIA-1 RRM23K complexes with RNA and DNA sequences (as indicated
in the key).
torsion angles - within the allowed regions and>98% of
the residues were in the energetically most favored regions
(Table 1).
The structural basis of nucleotide binding by TIA-1 RRM2
The structure of TIA-1 RRM2/TTT complex is shown
in Figure 5A. RRM2 adopts the classical  topol-
ogy with four -sheets packed against two -helices. The
RMSD of C atoms compared with the structure of apo-
RRM2 (PDB ID: 3BS9) is 0.441 (calculated for 71 C out
of 78), with the main difference between the molecules oc-
curring in the loop region between -strands 2 and 3 (Fig-
ure 5B). The nucleotides are positioned against the -sheet
face of the TIA-1 RRM2 as is the classical nucleotide bind-
ing face for RRMs (43). The surface is contoured, provid-
ing shallow binding pockets for each nucleotide and a pre-
dominantly positively charged surface accommodating the
oligonucleotide backbone (Figure 5C and Supplementary
Figure S7). The base interactions are mainly van der Waals
or hydrophobic, but aromatic stacking and several spe-
cific hydrogen bonds are also observed. The two conserved
phenylalanine residues (Phe98 and Phe140) located in the
RNP-2 and RNP-1 sub motifs of RRM2 interact directly
with Thy2 and Thy3 through aromatic base stacking. An-
other RNP-2 residue, Asp101, forms a hydrogen bond with
the Thy1 N3 atom and Arg167 interacts with the Thy1 O4
atom (Figure 5D, left). In the case of Thy2, the Asn169 N	2
and Trp170 backbone CO, located in 4 of RRM2, form
hydrogen bonds with Thy2 O4 and N3 atoms respectively
(Figure 5D, middle). Thirdly, in the case of Thy3, the His96
N	1 hydrogen bonds with the Thy3 O4 and the Arg125
guanidinium group is positioned to form electrostatic or
water mediated interactions with the oligonucleotide back-
bone (Figure 5D, right). It should be noted that the hydro-
gen bond and electrostatic interactions listed above could
not take place with other bases, with the exception of cy-
tosine in position 1, where it could potentially make sim-
ilar interactions with Arg167 via its O4 atom and engage
Asp101 via its NH2 group. Altogether, therefore, the struc-
ture reveals the interactions that contribute to the affinity
of nucleotide binding to TIA-1 RRM2 and also helps to
explain the preferential binding of TIA-1 RRM2 for uracil
and thymine nucleotides.
Nucleotide binding by TIA-1 RRM2 bears some re-
semblance to other characterized RRM/RNA interactions.
Figure 6 shows cartoon representations of closely related
RRM/RNA structures alongside TIA-1 RRM2/TTT as
well as a structure based sequence alignment. The oligonu-
cleotide orientation is the same in each case, with the 5′-
end closest to the C-terminal -strand, but the precise nu-
cleotide binding positions vary. TIA-1 RRM2 nucleotide
binding positions are most similar to those adopted by
HuRRRM2/UUU and PABPRRM2/AAA (though there
are also similarities between the binding position of T3
in HuR RRM1/UUU and CUGBP1/AUU). Interestingly,
however, there is no sequence similarity in the type of amino
acid interactions with targeted nucleotide bases, even in the
case of HuR RRM2 that also preferentially binds to U-
rich sequences. The only exception is the presence of aro-
matic residues in RNP1 and RNP2motifs that facilitate nu-
cleotide base stacking interactions.
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Figure 5. Structure of TIA-1 RRM2/TTT complex (PDB ID: 5ITH) (A) Cartoon representation of the solved TIA-1 RRM2 structure with electron den-
sity map indicating the position of the bound oligonucleotide. DNA is shown as sticks, colored by atom type. N-and C-termini as well as secondary
structural elements of the protein are labeled. (B) Superposition of the oligonucleotide-bound form of TIA-1 RRM2 (gray) with the apo-structure
previously reported (PDB ID: 3BS9). (C) Electrostatic surface contour representation, showing thymine binding pockets across the surface of TIA-
1 RRM2 and the oligonucleotide in stick representation. The surface was generated using the Adaptive Poisson-Boltzmann Solver software package
(http://www.poissonboltzmann.org). Positive and negative potentials are colored blue and red, respectively. (D) Detail of TIA-1 RRM2 sidechain interac-
tions with thymine in the three oligonucleotide binding sites. Hydrogen bond interactions are highlighted with hashed lines.
The interaction of TIA-1 RRM2 His96 with thymine is in
agreement with NMR experiments
A specific feature revealed by the TIA-1 RRM2 structure
bound to oligonucleotide was the hydrogen bond between
His96 N	1 hydrogen and the Thy2 O4 (Figure 5D, right).
This interaction likely explains the previously reported rise
in pKa value of His96 that occurs upon oligonucleotide
binding by TIA-1 RRM2 (28). The direct hydrogen bond-
ing of His96 N	1 would be expected to increase the nucle-
ophilicity of the N
2 atom of the imidazole and thus raise
the pKa. In order to further investigate this interaction we
performed 2D 1H-15N HSQC experiments that could pro-
vide a direct readout of the protonation state of the TIA-
1 RRM2 His96 sidechain and backbone nitrogens before
and after forming a complex with a 5′-TTTTT-3′ oligonu-
cleotide. At pH 5 (which is well below the His96 pKa value
of 5.3 for apo-TIA-1RRM2 andHis96 pKa of 5.6 for TIA-1
RRM2 bound to DNA; (28,29) the 1H-15N HSQC spectra
show a 2-fold increase in intensity for the N
2–H
2 cross-
peaks when the complex with DNA is formed (integrated
value of 1.075 for free peaks versus 2.167 for DNA-bound
signals in arbitrary units) (Figure 7). This is consistent with
its increased nucleophilicity. In addition, TheN	1–H	1 cou-
pling of His96 of TIA-1 RRM2 could not be seen for apo-
TIA-1 RRM2, but became detectable upon DNA complex
formation, in agreement with the formation of a hydrogen-
bond between His96 N	1 and Thy3 O4. It was also noted
that the His96 backbone NH coupling was shifted upon
complex formation with DNA, which is also in agreement
with involvement of His96 in the interaction. Together the
NMRdata corroborate the observed interaction in the crys-
tal structure.
DISCUSSION
TIA-1 and TIAR are critical proteins for alternative splic-
ing, translation repression and sequestration into stress
granules of mRNA targets. The current study has inves-
tigated the biophysical basis for oligonucleotide recogni-
tion and binding by TIA-1 that underlies these functions. It
has been previously established that RRM1 does not con-
tribute significantly to RNA binding, that RRM2 prefer-
entially binds to U-rich oligonucleotides and that RRM3
contributes to binding through its ability to bind to C-rich
sequences (20,26). The focus has thus been on the structural
basis of binding and recognition by the TIA-1 RRM23 con-
struct to UC-rich and CU-rich RNA and equivalent DNA
sequences. For this study 10-nt ssRNAand ssDNAwere uti-
lized for all biophysical and structural studies. This would
allow for recognition of up to 5-nt by each RRM. A foot-
print of 10 or 9-nt is in keeping with binding studies by
Wang et al., in which 1:1 stoichiometry was observed for
TIA-1 RRM23 binding to a 10-nt RNA, but 2:1 stoichiom-
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Figure 6. Comparison of the TIA-1 RRM2 structure with other RRM/RNA interactions. (A) Structural representations of RRM/oligonucleotide inter-
actions determined for HuR (PDB ID: 4ED5), CUGBP1 (PDB ID: 3NNH) and PCBP (PDB ID: 1CVJ) shown in the same orientation as that for TIA-1
RRM2/TTT. (B) Structure-based sequence alignment of the depicted RRMs. The TIA-1 RRM2 amino acids engaged in interactions with thymine are
colored in red (T1), green (T2) and blue (T3).
etry was observed for a 16-nt oligonucleotide (40). It is pos-
sible, however, that shorter oligonucleotides would be suffi-
cient for recognition and binding by TIA proteins.
Oligonucleotide binding affinity was found to be dra-
matically affected when amino acid residues outside of the
strictly defined RRM3 were included. In particular, the
presence of three extra N- and C-terminal residues en-
hanced the binding of TIA-RRM23 to RNA and DNA
targets by 50- and 100-fold respectively. This enhancement
likely reflects the contribution of the Lys274 positive charge
to the oligonucleotide binding. Lys274 is positioned at the
edge of the oligonucleotide binding face of RRM3 and thus
contributes to the electrostatic charge at this site. The inter-
action is entirely analogous to what was discovered by our
group in a separate study of the related TIAR RRM2 do-
main (39). The TIAR RRM2 domain affinity for oligonu-
cleotide was greatly enhanced by the amino acid residues
immediately C-terminal to the strictly defined RRM do-
main. In particular, Lys176 contributed to a 25- to 100-fold
enhancement of binding to RNA and DNA respectively.
This lysine is also conserved in TIA-1 (Lys174) and likely
also plays the same role in stabilizing oligonucleotide inter-
actions by TIA-1.
Interestingly, TIA-1 RRM23 binding to DNA sequences
was found to occur with similar or slightly enhanced bind-
ing affinity compared with that to equivalent RNA se-
quences. We have previously reported that, in the case of
TIAR, binding to T-rich DNA occurs with slightly reduced
affinity compared with U-rich RNA. This was shown to
be due to a combination of affinity loss owing to the ab-
sence of the 2′-hydroxyl groups and an affinity enhancement
imparted by the presence of the methyl groups of thymine
(44). TIAR and TIA-1 RRMs share high sequence identity
of ∼90% for RRMs of TIA-1b and TIARb and it is thus
likely that these factors are also at play in TIA-1 oligonu-
cleotide binding. Other RNA-binding proteins are far less
promiscuous when it comes to RNA versus DNA binding.
In the case of HuR, which is also an AU-rich RNA binding
protein with three RRMs, binding to equivalent DNA se-
quences resulted in a dramatic loss in binding affinity (44).
The ability of TIA-1 to bind to DNA may reflect its role in
alternative splicing. It has been proposed that TIA proteins
interact with single-stranded regions of DNA in chromatin
undergoing active transcription facilitating their shuttling
to pre-mRNA in preparation for subsequent splicing activ-
ity (11).
Having established that the TIA-1 RRM23K construct
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Figure 7. 1J (N-H) couplings of TIA-1 RRM2 domain. Overlapped 2D
15N-1H HSQC spectra of free TIA-1 RRM2 (cyan) and TIA-1 RRM2
in complex with 5′-TTTTT-3′ DNA (magenta). The 1J (N-H) couplings
of the single histidine (His96) from TIA-1 RRM2 construct are labeled.
The black arrow points out the chemical-shift perturbation of the back-
bone amide (N-H) resonance of His96 observed upon DNA addition. A
schematic structure of a histidine residue identifying different imidazole
groups involved in 1J couplings is also shown. H atoms are depicted in
white, N atoms in blue, O atoms in red and C atoms in brown.
forms stable interactions with target oligonucleotides,
we compared the binding affinity with other similarly
composed sequences. The initial CU-rich sequence (5′-
ACUCCUUUUU-3′) was designed based on established
RNA target sequences derived for RRM3 and RRM2 (26).
The binding motifs were arranged such that RNA bind-
ing could occur in the 3′ to 5′ direction from RRM2 to
RRM3 as seen for most other tandemRRMconstructs that
have been structurally investigated in complex with RNA
(43). Binding affinity was in the low micromolar range for
this oligonucleotide sequence, as it was for a similar se-
quence derived from the FAS mRNA TIA-1 target motif.
Furthermore, the binding affinity of TIA-1 RRM23K was
greater than thatmeasured for TIA-1RRM2 alone, demon-
strating that RRM3 contributes to binding. However, we
then measured the binding affinity of TIA-1 RRM23K
to a sequence in which the RRM target sequences were
placed in the reverse order, i.e. a UC-rich RNA sequence
(5′-UUUUUACUCC-‘3) and determined binding in the
nanomolar range. This finding suggested that a much more
favorable interaction of TIA-1 RRM23K takes place when
RRM2 and RRM3 target sequences are positioned in the
5′ to 3′ direction, which we subsequently verified using an
NMR spectroscopic approach. This arrangement is less
usual, but not unprecedented. Tandem RRMs of splicing
factor TDP-43 were also found to be arranged in a 5′ to
Figure 8. Model of TIA-1 RRM23 bound to a UC-rich RNA sequence.
(A) Model based on the TIA-1 RRM2/TTT structure reported herein
(PDB ID: 5ITH) positioned next to the TIA-1 RRM3 structure (PDB ID:
2MJN) bound to the oligonucleotide 5′-UUUUUACUCC-3′ in a 5′ to 3′
direction. The juxtaposition of the two RRMs and the interaction between
RRM3 and oligonucleotide is by structural homology to the PABP/poly-
A structure (PDB ID:1CVJ). The model demonstrates that the linker re-
gion is sufficiently long to reach from the RRM2C-terminus to the RRM3
C-terminus. (B) Topology diagram of themodel highlighting the 5′ to 3′ di-
rectionality of the TIA-1 RRM23 interaction with target oligonucleotide.
3′ direction upon their solution structure determination by
NMR spectroscopy (45).
Small angle X-ray scattering experiments confirmed that
the TIA-1 RRM23K construct forms a compact structure
in complex with the UC-rich sequence as well as the equiv-
alent TC-rich DNA sequence, again consistent with the en-
gagement of both RRM2 andRRM3 in the oligonucleotide
binding interaction. Interestingly, similar scattering data
were also observed for TIA-1 RRM23K in complex with
the CU-rich RNA and CT-rich DNA sequences––also con-
sistent with a compact structure forming but with a subtle
difference in structure or flexibility apparent. The scattering
data are similar to that reported for TIA-1 RRM23 binding
to a FAS pre-mRNA derived 16mer RNA (40) and TIA-1
RRM123 binding to a longer FAS mRNA sequence (25)
that both show that a more compact structure is formed
when TIA-1 RRMs engage with RNA.
With this information we trialled crystallization condi-
tions for complexes formed between TIA-1 RRM23K (and
TIA-1 RRM23L) both UC-rich and CU-rich RNA se-
quences and their equivalent DNA sequences. In three cases
diffracting crystals were achieved (with DNA rather than
RNA) and the structures solved, but in all cases onlyRRM2
bound to oligonucleotide was present in the crystal. It was
rationalized that limited proteolysis that occurred in the
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crystal trays were selectively crystallized. This occurred de-
spite the presence of complete protease inhibitor tablet in
the protein buffer. All three structures were solved, and
the one solved to the highest resolution is reported herein.
The structure revealed, for the first time, the TIA-1 RRM2
structure engaged with T-rich DNA. The oligonucleotide
sequence is positioned across the face of the TIA-1 RRM2
similarly to the interaction between PABPRRM2 and poly-
A in terms of the nucleotide binding arrangement. Hydro-
gen bond interactions were observed that help to explain the
preferential binding of U-rich or T-rich oligonucleotides.
In particular, an interaction between His96 and the third
thymine base provided structural verification of a previous
observation that the pKa of this histidine sidechain is im-
pacted by RNA binding (28,29). We further probed this us-
ing NMR and observed increased signal intensities of the
sidechainN-H signals uponDNAbinding, again consistent
with the formation of an oligonucleotide interaction with
His96.
Together the biophysical data permit the construction
of a model of the interaction between TIA-1 RRM23
and the UC-rich RNA target (Figure 8A). In this model,
RRM2 is positioned at the 5′-end of the oligonucleotide,
engaging with a U-rich pentamer by analogy to the TIA-1
RRM2/TTT crystal structure. RRM3 is positioned at the
3′-end of the DNA, engaged with the ACTCC sequence.
Here the RRM oligonucleotide interaction has been con-
structed based on the interaction observed between PABP
RRM2 and poly-A, as this RRM has the highest similar-
ity to TIA-1 RRM3 of any known RRM that has been
structurally characterized with oligonucleotide bound. Po-
sitioned in this way, Lys274 that occurs immediately C-
terminal toRRM3 is positioned close to the oligonucleotide
and could form electrostatic interactions with the phos-
phate backbone, explaining the importance of its contri-
bution to the binding affinity. The juxtaposition of RRM2
5′ to RRM3 requires the positioning of the linker region
across the RRM2 domain to reach the N-terminal 0-helix
of RRM3 (Figure 8B). This -helix, which occurs in ad-
dition to the conventional  topology of an RRM
(27), is positioned away from the oligonucleotide binding
face of RRM3. The linker between RRM2 and RRM3 is
long enough to extend between RRM2 and RRM3without
a structural distortion––but it would not be unexpected for
a small rearrangement to take place that would reduce any
strain imposed of this linker region. Indeed, HSQC titra-
tion mapping of the amino acid residues of TIA-1 RRM23
that are perturbed upon oligonucleotide binding show that,
as well as perturbations to the oligonucleotide binding faces
of RRM2 and RRM3, the 0-helix on RRM3 is also per-
turbed (40).
TIA-1 proteins possess varied functions in post-
transcriptional gene regulation, including interactions
with splicing factors, mRNA translational control and
mRNA sequestration into stress granules––all of which
involve oligonucleotide binding. The current biophysical
and structural studies provide a better understanding of
the structural arrangement and requirements for binding to
linear RNA and DNA sequences. This lays the foundation
for future studies to discover the precise arrangement of the
tandem RRMs, the structural basis for RRM3 recognition
of C-rich targets and whether there are other elements
of oligonucleotide secondary structure that may also be
important for binding. Such studies will be important
for ultimately understanding the mechanistic role of TIA
proteins in their various cellular functions.
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